$ACRS 4 SEC Filings

Filed On	Filing
04 Aug 2026	Form 4: Kolbeck Roland Wilhelm, Chief Scientific Officer Received 36,375 shares by exercise or conversion · Gave up 12,385 shares to cover exercise price or tax ($64.4K)
08 Jun 2026	Form 4: Mehra Anand, Director Granted 42,350 Stock Option (Right to Buy) · Granted 10,987 Restricted Stock Units · Received 11,580 shares by exercise or conversion
08 Jun 2026	Form 4: Schiff Andrew N, Director Granted 42,350 Stock Option (Right to Buy) · Granted 10,987 Restricted Stock Units · Received 11,580 shares by exercise or conversion
08 Jun 2026	Form 4: Humphries William D., Director Granted 42,350 Stock Option (Right to Buy) · Granted 10,987 Restricted Stock Units · Received 11,580 shares by exercise or conversion
08 Jun 2026	Form 4: Molineaux Christopher P., Director Granted 42,350 Stock Option (Right to Buy) · Granted 10,987 Restricted Stock Units · Received 11,580 shares by exercise or conversion
08 Jun 2026	Form 4: Milano Vincent, Director Granted 42,350 Stock Option (Right to Buy) · Granted 10,987 Restricted Stock Units · Received 11,580 shares by exercise or conversion
08 Jun 2026	Form 4: Gowen Maxine, Director Granted 42,350 Stock Option (Right to Buy) · Granted 10,987 Restricted Stock Units · Received 11,580 shares by exercise or conversion
05 May 2026	Form 4: Hall Jesse Wayne, Chief Medical Officer Received 36,375 shares by exercise or conversion · Gave up 9,330 shares to cover exercise price or tax ($41.1K)
27 Apr 2026	Form 4: Leonard Braden Michael, 10% owner Sold 300,000 shares ($1.36M)
03 Mar 2026	Form 4: Balthaser Kevin, Chief Financial Officer Received 2,375 shares by exercise or conversion · Gave up 677 shares to cover exercise price or tax ($1.94K)
06 Feb 2026	Form 4: Walker Neal, Director Granted 274,800 Restricted Stock Units · Granted 961,700 Employee Stock Option (Right to Buy)
06 Feb 2026	Form 4: Davis Hugh M., Director Granted 96,100 Restricted Stock Units · Granted 336,300 Employee Stock Option (Right to Buy)
06 Feb 2026	Form 4: Kolbeck Roland Wilhelm, Chief Scientific Officer Granted 95,700 Restricted Stock Units · Granted 334,900 Employee Stock Option (Right to Buy)
06 Feb 2026	Form 4: Hall Jesse Wayne, Chief Medical Officer Granted 98,100 Restricted Stock Units · Granted 343,300 Employee Stock Option (Right to Buy)
06 Feb 2026	Form 4: Loerop James, Chief Business Officer Granted 97,700 Restricted Stock Units · Granted 341,900 Employee Stock Option (Right to Buy)
06 Feb 2026	Form 4: Balthaser Kevin, Chief Financial Officer Granted 99,100 Restricted Stock Units · Granted 346,800 Employee Stock Option (Right to Buy)
05 Feb 2026	Form 4: Loerop James, Chief Business Officer Received 20,875 shares by exercise or conversion · Gave up 5,937 shares to cover exercise price or tax ($20.6K)
05 Feb 2026	Form 4: Walker Neal, Director Received 63,475 shares by exercise or conversion · Gave up 18,611 shares to cover exercise price or tax ($64.6K)
05 Feb 2026	Form 4: Davis Hugh M., Director Received 18,675 shares by exercise or conversion
05 Feb 2026	Form 4: Balthaser Kevin, Chief Financial Officer Received 22,025 shares by exercise or conversion · Gave up 6,449 shares to cover exercise price or tax ($22.4K)

Comments